Group One Trading
ANVS icon

Group One Trading’s Annovis Bio ANVS Stock Holding History

Group One Trading’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789K Buy
424,400
+416,000
+4,952% +$809K ﹤0.01% 3101
2026
Q1 		$18.7K Sell
8,400
-1,600
-16% -$4.39K ﹤0.01% 6007
2025
Q4 		$34.6K Buy
10,000
+8,500
+567% +$25.5K ﹤0.01% 5898
2025
Q3 		$3.1K Buy
1,500
+300
+25% +$750 ﹤0.01% 7756
2025
Q2 		$2.6K Sell
1,200
-1,600
-57% -$3.16K ﹤0.01% 7330
2025
Q1 		$4.2K Sell
2,800
-10,900
-80% -$33.4K ﹤0.01% 6725
2024
Q4 		$68.9K Sell
13,700
-174,700
-93% -$1.26M ﹤0.01% 4820
2024
Q3 		$1.52M Sell
188,400
-530,900
-74% -$4.97M ﹤0.01% 1947
2024
Q2 		$4.14M Buy
719,300
+571,400
+386% +$4.63M 0.02% 926
2024
Q1 		$1.76M Buy
+147,900
New +$1.61M 0.01% 1588

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Group One Trading's ANVS Position: Q2 2026 in Review

Group One Trading sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 69,663 shares — an estimated $135K sold.

Group One Trading first reported a position in ANVS in Q3 2024 and held it in 7 quarters. The position peaked at $425K in Q3 2024. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Group One Trading reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 69,663 Annovis Bio shares in Q2 2026, an estimated $135K.
  • Group One Trading first reported a position in Annovis Bio in Q3 2024 and held it in 7 quarters.
  • Group One Trading's Annovis Bio position peaked at $425K in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.